Founded in 2010, The Native Antigen Company has rapidly become one of the world’s leading suppliers of infectious disease reagents. Our portfolio of reagents continues to expand rapidly, and we are widely acknowledged to be a primary source of reagents and kits for studying emerging diseases.
Our customers include leading pharmaceutical vaccine manufacturers, large diagnostic companies and leading academic groups around the world.
At The Native Antigen Company our goal is to provide products that help overcome the challenges presented by infectious diseases around the world. We aim to develop cutting edge reagents to enable research into vaccine development and diagnostics that will ultimately reduce the burden of global infection. We provide truly excellent service and look to develop close and long term relationships with our partners and customers.
In addition to producing world-leading reagents for infectious disease, we believe we have a responsibility to our customers, our staff and to the planet to behave ethically and sustainably in running our business. We will always be open and honest in all of our communications with customers. We also strive to minimise our environmental footprint, exemplified by our use of 100% renewable energy, and recycled packaging wherever possible.